Abstract
The role of cytosine methylation in the regulation of gene expression during normal development and malignant transformation is currently under intense investigation. An ever increasing body of evidence demonstrates that carcinogenesis is associated with aberrant DNA methylation of the promoters of tumor suppressor genes (Chin Med J (Engl) 111:1028-1030, 1998; Leukemia 17:2533-2535, 2003), hypomethylation of oncogenes (Toxicol Appl Pharmacol 206:288-298, 2005; Toxicology 50:231-245, 1988), and concurrent loss of methylation in the intergenic areas and gene bodies, which may lead to genomic instability and chromosomal fragility (Cytogenet Cell Genet 89:121-128, 2000). Single locus methylation assays have focused largely on specific known tumor suppressor genes or oncogenes (Chin Med J (Engl) 111:1028-1030, 1998; Cancer Res 57:594-599, 1997; Hum Genet 94:491-496, 1994; Mol Cell Biol 14:4225-4232, 1994; Gastroenterology 116:394-400, 1999). Such approaches, while being useful, have clear limitations. With the advent of genome-wide microarray-based techniques, it has become possible to perform genome-wide exploratory studies to better understand genomic patterning of DNA methylation and also to discover new potential disease-specific epigenetic lesions (J Cell Biochem 88:138-143, 2003; Genome Res 16:1075-1083, 2006). In order to capture this type of information from primary human tissues, we have adopted and optimized the HELP assay (HpaII tiny fragment Enrichment by Ligation-mediated PCR) to compare and contrast the abundance of cytosine methylation of genomic regions that are relatively enriched for CpG dinucleotides. While we have mainly used a custom NimbleGen-Roche high-density oligonucleotide microarray containing 25,626 HpaII amplifiable fragments, many other microarray platforms or high throughput sequencing strategies can be used with HELP.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Chen W, Zhu J, Liu J, Tan S (1998) Methylation of p16 gene in hematological malignancies. Chin Med J (Engl) 111:1028-1030
Chim CS, Fung TK, Liang R (2003) Disruption of INK4/CDK/Rb cell cycle pathway by gene hypermethylation in multiple myeloma and MGUS. Leukemia 17:2533-2535
Benbrahim-Tallaa L, Waterland RA, Styblo M, Achanzar WE, Webber MM, Waalkes MP (2005) Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. Toxicol Appl Pharmacol 206:288-298
Bhave MR, Wilson MJ, Waalkes MP (1988) Methylation status and organization of the metallothionein-I gene in livers and testes of strains of mice resistant and susceptible to cadmium. Toxicology 50:231-245
Tuck-Muller CM, Narayan A, Tsien F, Smeets DF, Sawyer J, Fiala ES et al (2000) DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogenet Cell Genet 89:121-128
Gonzalgo ML, Liang G, Spruck CH III, Zingg JM, Rideout WM III, Jones PA (1997) Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res 57:594-599
Greger V, Debus N, Lohmann D, Hopping W, Passarge E, Horsthemke B (1994) Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum Genet 94:491-496
Magewu AN, Jones PA (1994) Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol Cell Biol 14:4225-4232
Matsuda Y, Ichida T, Matsuzawa J, Sugimura K, Asakura H (1999) p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology 116:394-400
Shi H, Maier S, Nimmrich I, Yan PS, Caldwell CW, Olek A et al (2003) Oligonucleotide-based microarray for DNA methylation analysis: principles and applications. J Cell Biochem 88:138-143
Bibikova M, Chudin E, Wu B, Zhou L, Garcia EW, Liu Y, Shin S et al (2006) Human embryonic stem cells have a unique epigenetic signature. Genome Res 16:1075-1083
Kawamata N, Inagaki N, Mizumura S, Sugimoto KJ, Sakajiri S, Ohyanagi-Hara M et al (2005) Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders. Eur J Haematol 74:424-429
Heard E, Clerc P, Avner P (1997) X-chromosome inactivation in mammals. Annu Rev Genet 31:571-610
Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042-2054
Kay PH, Spagnolo DV, Taylor J, Ziman M (1997) DNA methylation and developmental genes in lymphomagenesis-more questions than answers? Leuk Lymphoma 24:211-220
Klangby U, Okan I, Magnusson KP, Wendland M, Lind P, Wiman KG (1998) p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt’s lymphoma. Blood 91:1680-1687
Klose RJ, Bird AP (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31:89-97
Klose RJ, Sarraf SA, Schmiedeberg L, McDermott SM, Stancheva I, Bird AP (2005) DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol Cell 19:667-678
Esteve PO, Chin HG, Smallwood A, Feehery GR, Gangisetty O, Karpf AR et al (2006) Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev 20:3089-3103
Fung MK, Au WY, Liang R, Srivastava G, Kwong YL (2003) Aberrant promoter methylation in gastric lymphoma. Haematologica 88:231-232
Gronbaek K, Hother C, Jones PA (2007) Epigenetic changes in cancer. Apmis 115:1039-1059
Henrickson SE, Hartmann EM, Ott G, Rosenwald A (2007) Gene expression profiling in malignant lymphomas. Adv Exp Med Biol 593:134-146
Issa JP (2000) The epigenetics of colorectal cancer. Ann N Y Acad Sci 910:140-153, discussion 153-5
Issa JP (2004) CpG island methylator phenotype in cancer. Nat Rev Cancer 4:988-993
Khulan B, Thompson R, Ye K, Fazzari MJ, Suzuki M, Stasiek E, Figueroa ME et al (2006) Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res 16:1046-1055
Figueroa ME, Reimers M, Thompson RF, Ye K, Li Y, Selzer RR et al (2008) An integrative genomic and epigenomic approach for the study of transcriptional regulation. PLoS One 3:e1882
Figueroa ME, Wouters BJ, Skrabanek L, Glass J, Li Y, Erpelinck-Verschueren CA, Langerak M et al (2009) Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features. Blood 113:2795-2804
Fazzari MJ, Greally JM (2004) Epigenomics: beyond CpG islands. Nat Rev Genet 5:446-455
Glass JL, Thompson RF, Khulan B, Figueroa ME, Olivier EN, Oakley EJ et al (2007) CG dinucleotide clustering is a species-specific property of the genome. Nucleic Acids Res 35:6798-6807
Oda M, Greally JM (2009) The HELP assay. Methods Mol Biol 507:77-87
Thompson RF, Reimers M, Khulan B, Gissot M, Richmond TA, Chen Q et al (2008) An analytical pipeline for genomic representations used for cytosine methylation studies. Bioinformatics 24:1161-1167
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Shaknovich, R., Figueroa, M.E., Melnick, A. (2010). HELP (HpaII Tiny Fragment Enrichment by Ligation-Mediated PCR) Assay for DNA Methylation Profiling of Primary Normal and Malignant B Lymphocytes. In: Chittur, S.V. (eds) Microarray Methods for Drug Discovery. Methods in Molecular Biology, vol 632. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-663-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-60761-663-4_12
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-662-7
Online ISBN: 978-1-60761-663-4
eBook Packages: Springer Protocols